Molecular Diagnostics Market Attractive Industry Opportunities by 2024: Grand View Research Inc.

San Francisco, 28 January 2019: The Report Molecular Diagnostics Market Size, Share & Trend Analysis Report By Technology (PCR, ISH, INNAT, Chips & Microarrays, Mass spectrometry, Sequencing, TMA), And Segment Forecasts, 2018 - 2024

Global molecular diagnostics market is expected to reach over USD 17.9 billion by 2024, based on a new report by Grand View Research, Inc. Increasing prevalence of infectious diseases including human papillomavirus and influenza is expected to be the primary driving force for the growth of the molecular diagnostics market. In the underdeveloped regions of Africa and Nigeria, other infections, such as HIV and tuberculosis, are soaring at a high growth rate since the last few years. This is estimated to increase the demand for early and accurate diagnostic techniques to curb their growth rate.

Prenatal genetic testing, performed for the purpose of early detection of abnormalities that develop in the fetuses of carrier parents, is also expected to widen the client base for the molecular diagnostics market. Moreover, the high adoption of unhealthy lifestyles further resulting in a large patient count afflicted with chronic diseases, such as diabetes and cardiovascular disorders, is also projected to positively impact the growth.

Access Research Report of Molecular Diagnostics Market @ www.grandviewresearch.com/industry-analysis/molecular-diagnostics-market

Further key findings from the study suggest:

·       The overall market is dominated by reagents with revenue generation of over USD 2.3 billion in 2015 owing to their elevated usage rates. Reagents are key products used in academic and research institutes to perform various molecular biology protocols further contributing toward the dominance of this segment.

·       Instruments, such as PCR and next generation sequencing platforms, are being widely preferred by central laboratories and diagnostic institutes due to the rapid nature of these tests in delivering quick & reliable results and the high volume of diagnostic procedures in this segment. Thus, this segment is expected to maintain a constant growth at a CAGR of around 9.0%.

·       Central laboratories led the global molecular diagnostics market by test location with revenue generation of around USD 4.0 billion in 2015 owing to their established base in the remote and developing regions

·       On the other hand, the point of care devices segment witnessed the fastest growth with a CAGR of over 14.0%. The associated advantages include the user-friendly nature of these tests and quick healthcare delivery, which are estimated to propel the molecular diagnostics market.

·       Infectious diseases held the largest share of over USD 2.9 billion in 2015. Molecular testing tools provide clinicians with better alternatives to detect countless infectious bacteria, virus, and pathogens in short time while delivering highly accurate results. Initiatives led by organizations, such as the WHO, in conducting diagnostic programs in regions with high risk areas is estimated to be a high rendering driver.

·       The oncology segment is expected to exhibit a CAGR of around 13.0% over the forecast period. Rising awareness levels among people as well as healthcare professionals for cancer diagnosis is a key attribute propelling the market growth.

·       The PCR segment dominated the market with revenue generation of over USD 2.6 billion in 2015, attributable to the growing applications of multiplex PCR over the conventional PCR procedure and the introduction of easy-to-use PCR handling kits.

·       North America was observed to be the largest regional segment in 2015 with a share of over 45.0%. Key factors contributing toward the large share are well-established healthcare infrastructure, rising healthcare spending, increasing awareness levels among patients, and expansion of R&D activities related to drug discovery and development.

·       Asia Pacific is identified as a lucrative segment with a CAGR of approximately 17.0% over the forecast period. Rising demand for improved diagnostic technologies employed for the prevention of epidemics, unaddressed clinical needs, and recent activities by key players targeting expansion in this region are the major factors supporting the market growth.

·       Some of the major players include Novartis AG (Grifols), Siemens Healthcare GmbH, Bio-Rad Laboratories, Inc., Alere, Inc., Danaher Corporation, bioMérieux SA, Sysmex Corporation, Becton, Dickinson and Company, Johnson & Johnson Services, Inc., Bio-Rad Laboratories, Inc., Bayer AG, Qiagen, Hologic, Inc. (Gen Probe), Cepheid, F. Hoffmann-La Roche Ltd, and Dako

·       The key players are advancing strategic collaborations with major technology-based companies & diagnostic centers and expanding into the developing regions in an attempt to increase their market share and attain stability

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global molecular diagnostics market on the basis of product, technology, applications, test location, and region:

Global Molecular Diagnostics Product Outlook (Revenue, USD Million, 2013 - 2024)

·         Instruments

·         Reagents

·         Others

Global Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2013 - 2024)

·         PCR

·         In-situ Hybridization

·         Chips and microarrays

·         Mass spectrometry

·         Sequencing

·         Transcription mediated amplification

·         Others

Global Molecular Diagnostics Application Outlook (Revenue, USD Million, 2013 - 2024)

·         Oncology

·         Pharmacogenomics

·         Infectious Diseases

·         Genetic Testing

·         Neurological diseases

·         Cardiovascular diseases

·         Others

Global Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2012 - 2024)

·         Point of care

·         Self test or OTC

·         Central laboratories

Molecular Diagnostics Regional Outlook (Revenue, USD Million, 2012 - 2024)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Molecular Diagnostics Market@ www.grandviewresearch.com/press-release/global-molecular-diagnostics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Moisture Wound Dressing Market to Witness Exponential Growth by 2025: Grand View Research Inc.

San Francisco, 28 January 2019: The Report Moist Wound Dressings Market Size, Share & Trends Analysis Report By Product (Foam, Films), By Application (Surgical Wound, Diabetic Ulcer), By End Use (Hospital, Homecare), And Segment Forecasts, 2018 - 2025

The global moisture wound dressing market size is expected to reach USD 5.45 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to witness a CAGR of 5.6% over the forecast period. Key factor driving the market are increasing cases of acute and chronic wounds, such as surgical, diabetic and traumatic wounds, lacerations, and diabetic ulcers. As per estimates provided by Elsevier, about 300 million acute wound injuries occur per year.

Ongoing R&D in the healthcare field is leading to the development of new products. For instance, the advent of keratin-based wound care products. These products facilitate wound re-epithelialization but also forms part of dressings and aid in wound healing as the keratin matrix in them gets absorbed in the wound eliminating the need to change the dressing. Furthermore, introduction of novel therapies, such as electromagnetic therapy, electrical stimulation, nanotechnology, and the use of silver and other combination dressings are boosting the market.

These advancements ensure better wound care during any trauma, thereby supporting the market growth. Similarly, new products in pipeline are anticipated to augment the market development over the forecast period. For instance, Researchers in Massachusetts Institute of Technology in U.S. and University of Nebraska-Lincoln, Harvard Medical School have developed a bandage that provides precise and scheduled drug delivery, which can be customized as per requirement. Such innovations are expected to create growth opportunities for the market players.

Access Research Report of Moisture Wound Dressing Market @ www.grandviewresearch.com/industry-analysis/moist-wound-dressings-market

Further key findings from the report suggest:

·       On the basis of product, foam wound dressings account for the largest share owing to their ability to maintain moisture, which facilitates healing process

·       Surgical application segment accounts for the largest market share due to increasing number of surgical procedures being performed; as all types of wound dressings are required during surgeries

·       Southeast Asia moist wound dressings market is expected to witness significant development as the region holds potential growth opportunities due to the presence of, emerging nations like Indonesia and Thailand

·       The diabetic ulcer segment is anticipated to witness the highest CAGR during the forecast period on account of increasing prevalence of the disease and related complications

·       Key companies in the market are 3M Healthcare; Coloplast A/S; Medline Industries, Inc.; Cardinal Health, Inc.; B. Braun Melsungen AG; Smith & Nephew PLC; ConvaTec Group PLC; Derma Sciences, Inc.; and Systagenix Wound Management Ltd.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global Moisture wound dressings market on the basis of product, application, end use, and region:

Moisture Wound Dressings Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Foam

·         Alginate

·         Films

·         Hydrocolloid

·         Hydrogel

Moisture Wound Dressings Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Pressure Ulcers

·         Diabetic Ulcers

·         Burn Wounds

·         Surgical Wounds

·         Traumatic Wounds

·         Others

Moisture Wound Dressings End-use Outlook (Revenue, USD Million, 2014 - 2025)

·         Hospitals

·         Homecare

·         Others

Moisture Wound Dressings Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         U.S.

·         Europe

·         Southeast Asia

·         Central & South America

·         Rest of the World

Access Press Release of Moisture Wound Dressing Market@ www.grandviewresearch.com/press-release/global-moist-wound-dressings-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Plasma Protein Therapeutics Market is Set To Witness a CAGR of 4.8% from 2018 to 2025: Grand View Research Inc.

San Francisco, 28 January 2019: The Report Plasma Protein Therapeutic Market Size, Share & Trends Analysis Report By Product (Albumin, Immunoglobulin, Factor VIII), By Application (Hemophilia, PID, ITP), By Region, And Segment Forecasts, 2018 - 2025

The global plasma protein therapeutics market size is expected to reach USD 33.15 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 4.8% over the forecast period. The growth can be attributed to high prevalence of bleeding and other rare disorders, rising investment in R&D, and increasing use of plasma-derived products in neurology and other therapeutic indications.

Plasma-derived proteins are primarily used as replacement therapies to treat chronic, rare diseases. Patients that rely on these medications require regular injections or infusions throughout their lives. While there are more than 250 products derived from plasma, key players generally rely on Immunoglobulin (IG), albumin, and factor VIII to drive sales and profitability.

Over the past decade, the plasma protein therapeutics market has grown lucratively with immunoglobulin capturing the major market share. Demand for plasma derived-products is driven by rising disease prevalence, geriatric population, and improved access to drugs in emerging markets. Approvals of new plasma-derived therapies are anticipated to further fuel the demand. Developing countries such as China and Brazil offer new investment avenues to the global market giants.

Access Research Report of Plasma Protein Therapeutics Market @ www.grandviewresearch.com/industry-analysis/plasma-protein-therapeutic

Further key findings from the report suggest:

·       Germany leads the European market, supported by high demand for blood components, presence of key players, large addressable population, and rising disease prevalence

·       Demand for immunoglobulin is expected to continue rising owing to prevalence of primary immunodeficiencies, usage in new indications, and ease of administration

·       Non-plasma based recombinant therapies are likely to compete with plasma-derived products in the factor VIII market

·       Asia Pacific is expected to exhibit high growth over the forecast period fueled by increasing healthcare expenditure, presence of a large number patients. improved ratio of patients suffering from disease and patients receiving treatment, low-cost production of drugs, and improvement in diagnostic technology.

·       Major players operating in the plasma protein therapeutics market include CSL Behring, Grifols, S.A., Shire Plc, Octapharma AG, Biotest AG, and Kedrion S.P.A. Regional expansion, broad product portfolio, and merger & acquisitions are chief strategic undertakings adopted by key players.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the global plasma protein therapeutics market on the basis of product, application, and region:

Plasma Proteins Therapeutics Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Albumin

·         Immunoglobulin

·         Factor VIII

Plasma Proteins Therapeutics Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Hemophilia

·         Primary Immunodeficiency Disorder (PID)

·         Idiopathic Thrombocytopenic Purpura (ITP)

·         Others

Plasma Protein Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East and Africa (MEA)

Access Press Release of Plasma Protein Therapeutics Market@ www.grandviewresearch.com/press-release/global-plasma-protein-therapeutics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Travel Retail Market Size Is Predicted To Reach A Valuation Of USD 128.80 Billion By 2025: Grand View Research Inc.

San Francisco, 28 January 2019: The Report Travel Retail Market Size, Share & Trends Analysis Report By Channel (Down Town & Hotel Shops, Airports), By Product (Wine & Spirit, Fashion & Accessories, Perfume & Cosmetics), And Segment Forecasts, 2018 - 2025

The global travel retail market size is expected to reach USD 128.80 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at a strong CAGR of 8.7% over the forecast years. Rapidly expanding retail and travel and tourism industry along with increasing per capita income levels is expected to drive the market growth. Different retail channels help in improving the retail experience of the passengers while contributing to economic growth.

The airport retail segment is expected to gain traction over the forecast period and is expected to reach over USD 91.75 billion by 2025. On the basis of products, perfume & cosmetics segment held a significant share of the market in 2017. Driven by the rising demand for branded cosmetics, such as makeup and skin care products, which are available discounted rates at the duty-free stores, the segment is projected to expand further.

The travel retail industry is focusing on enhancing customer experience and use data to provide customers an integrated experience. For example, Kuala Lumpur International Airport has integrated big data platform deployed for its KLIA2 terminal. This platform will extract passenger’s real-time location throughout the airport for real-time status check, travel plans, and so on.

Access Research Report of Travel Retail Market@ www.grandviewresearch.com/industry-analysis/travel-retail-market

Further key findings from the study suggest:

·       The global market accounted for USD 67.3 billion in 2017 and is expected to register a CAGR of 8.7% from 2018 to 2025

·       Increasing number of international travelers across the globe is expected to boost the market growth

·       The perfume & cosmetics segment is anticipated to witness the highest CAGR of 9.9% followed by the fashion & accessories segment over the forecast period

·       Asia Pacific is anticipated to be the fastest-growing regional market due to increasing disposal income levels and expanding travel industry in the region

·       Key companies in the global travel retail market include Shilla DFS, Lagardre Group, Lotte Corp., Heinemann, and Dufry AG

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the global travel retail market on the basis product, channel, and region:

Travel Retail Product Outlook (Revenue, USD Million, 2015 - 2025)

·         Perfume & Cosmetics

·         Confectionery & Fine Food

·         Wine & Spirit

·         Fashion & Accessories

·         Electronics

·         Tobacco

·         Others

Travel Retail Channel Outlook (Revenue, USD Million, 2015 - 2025)

·         Airports

·         Cruise Lines

·         Border, Down Town & Hotel Shops

·         Railway Stations & Others

Travel Retail Regional Outlook (Revenue, USD Million, 2015 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Travel Retail Market@ www.grandviewresearch.com/press-release/global-travel-retail-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com